The American Journal of Managed Care

After FDA Approval, EMA Accepts Marketing Authorization Application for First Oral SMA Therapy

The FDA approved the drug on August 7, and on August 17, the European Medicines Agency (EMA) accepted the marketing authorization application for the spinal muscular atrophy (SMA) treatment. Spinal ...
pv magazine International

SMA expands sunny portal accessibility with new android application

Smartphone users with the Android operating system can now access critical performance data from any photovoltaic (PV) system on the SMA Sunny Portal, the world s largest Web-based PV monitoring ...
Business Wire

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...
Hosted on MSN

Scholar Rock submits FDA application for SMA treatment

CAMBRIDGE, Mass. - Scholar Rock (NASDAQ: SRRK), a biopharmaceutical company with a market capitalization of $3.96 billion and an impressive 362.73% stock price surge over the past six months, ...
pv magazine International

SMA Presents its new energy solutions at Intersolar 2017

New Energy Solutions for all areas of application: SMA Solar Technology AG (SMA) will be exhibiting at Intersolar Europe 2017 in Munich as a provider of system solutions, presenting an entirely new, ...